These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32565036)

  • 1. Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases.
    Guijarro-Castro C; Rosón-González M; Abreu A; García-Arratibel A; Ochoa-Mulas M
    Neurologia (Engl Ed); 2020; 35(6):412-415. PubMed ID: 32565036
    [No Abstract]   [Full Text] [Related]  

  • 2. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases.
    Assini A; Benedetti L; Di Maio S; Schirinzi E; Del Sette M
    Neurol Sci; 2020 Jul; 41(7):1657-1658. PubMed ID: 32468450
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia.
    Su XW; Palka SV; Rao RR; Chen FS; Brackney CR; Cambi F
    Muscle Nerve; 2020 Aug; 62(2):E48-E49. PubMed ID: 32445201
    [No Abstract]   [Full Text] [Related]  

  • 4. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection.
    Chan JL; Ebadi H; Sarna JR
    Can J Neurol Sci; 2020 Nov; 47(6):852-854. PubMed ID: 32468972
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy.
    Tard C; Maurage CA; de Paula AM; Cassim F; Delval A; Kuchcinski G; Davion JB; Defebvre L; Bouchiba M; ; Jourdain M; Boucraut J
    Neurophysiol Clin; 2020 Oct; 50(5):397-399. PubMed ID: 33190687
    [No Abstract]   [Full Text] [Related]  

  • 6. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

  • 7. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report.
    Riva N; Russo T; Falzone YM; Strollo M; Amadio S; Del Carro U; Locatelli M; Filippi M; Fazio R
    J Neurol; 2020 Sep; 267(9):2492-2494. PubMed ID: 32458192
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guillain-Barré Syndrome Associated with SARS-CoV-2 infection].
    Esteban Molina A; Mata Martínez M; Sánchez Chueca P; Carrillo López A; Sancho Val I; Sanjuan-Villarreal TA
    Med Intensiva (Engl Ed); 2020 Nov; 44(8):513-514. PubMed ID: 32532531
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré Syndrome Associated with SARS-CoV-2.
    Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
    N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
    [No Abstract]   [Full Text] [Related]  

  • 11. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review.
    Trujillo Gittermann LM; Valenzuela Feris SN; von Oetinger Giacoman A
    Neurologia (Engl Ed); 2020; 35(9):646-654. PubMed ID: 32896460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome following COVID-19: new infection, old complication?
    Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M
    J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166
    [No Abstract]   [Full Text] [Related]  

  • 14. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK.
    Tiet MY; AlShaikh N
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute meningoencephalitis in a patient with COVID-19.
    Chaumont H; Etienne P; Roze E; Couratier C; Roger PM; Lannuzel A
    Rev Neurol (Paris); 2020 Jun; 176(6):519-521. PubMed ID: 32414534
    [No Abstract]   [Full Text] [Related]  

  • 16. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
    Juliao Caamaño DS; Alonso Beato R
    J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
    Marta-Enguita J; Rubio-Baines I; Gastón-Zubimendi I
    Neurologia (Engl Ed); 2020 May; 35(4):265-267. PubMed ID: 32364124
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain-Barré syndrome associated with SARS-CoV-2 infection.
    Velayos Galán A; Del Saz Saucedo P; Peinado Postigo F; Botia Paniagua E
    Neurologia (Engl Ed); 2020 May; 35(4):268-269. PubMed ID: 32364123
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
    Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y
    Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome after covid-19 infection.
    García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
    Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.